Diltiazem Hydrochloride is a drug owned by Biovail Laboratories Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jun 25, 2013. Details of Diltiazem Hydrochloride's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5529791 | Extended release form of diltiazem |
Jun, 2013
(11 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Diltiazem Hydrochloride is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Diltiazem Hydrochloride's family patents as well as insights into ongoing legal events on those patents.
Diltiazem Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Diltiazem Hydrochloride's generic launch date based on the expiry of its last outstanding patent is estimated to be Jun 25, 2013 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Diltiazem Hydrochloride Generic API suppliers:
Diltiazem Hydrochloride is the generic name for the brand Diltiazem Hydrochloride. 37 different companies have already filed for the generic of Diltiazem Hydrochloride, with Actavis Labs Fl Inc having the maximum number of approved applications. Check out the entire list of companies who have already received approval for Diltiazem Hydrochloride's generic
Alternative Brands for Diltiazem Hydrochloride
There are several other brand drugs using the same active ingredient (Diltiazem Hydrochloride) as Diltiazem Hydrochloride. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |||
|---|---|---|---|---|
| Bausch |
|
Apart from brand drugs containing the same ingredient, some generics have also been filed for Diltiazem Hydrochloride, Diltiazem Hydrochloride's active ingredient. Check the complete list of approved generic manufacturers for Diltiazem Hydrochloride
About Diltiazem Hydrochloride
Diltiazem Hydrochloride is a drug owned by Biovail Laboratories Inc. Diltiazem Hydrochloride uses Diltiazem Hydrochloride as an active ingredient. Diltiazem Hydrochloride was launched by Biovail in 2000.
Approval Date:
Diltiazem Hydrochloride was approved by FDA for market use on 28 January, 2000.
Active Ingredient:
Diltiazem Hydrochloride uses Diltiazem Hydrochloride as the active ingredient. Check out other Drugs and Companies using Diltiazem Hydrochloride ingredient
Dosage:
Diltiazem Hydrochloride is available in capsule, extended release form for oral use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 120MG | CAPSULE, EXTENDED RELEASE | Discontinued | ORAL |
| 180MG | CAPSULE, EXTENDED RELEASE | Discontinued | ORAL |
| 240MG | CAPSULE, EXTENDED RELEASE | Discontinued | ORAL |
| 300MG | CAPSULE, EXTENDED RELEASE | Discontinued | ORAL |